Dr. Lal PathLabs Limited — research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Dr. Lal PathLabs Limited, explained in plain English.

• ▪Dr. Lal PathLabs Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪Reported fundamentals show a net margin of 18.75%, debt to equity of 7.83.
• ▪Our transparent MaxGrade checklist scores it B (71/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 28.7% with a maximum drawdown of -19.65%.

Last traded values from 6 Oct 2026. Market closed.